Found: 7
Select item for more details and to access through your institution.
STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 430, doi. 10.3390/vaccines12040430
- By:
- Publication type:
- Article
Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice.
- Published in:
- Journal of Biomedical Science, 2022, v. 29, n. 1, p. 1, doi. 10.1186/s12929-022-00864-5
- By:
- Publication type:
- Article
Localization of Salmonella and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity.
- Published in:
- Journal of Biomedical Science, 2022, v. 29, n. 1, p. 1, doi. 10.1186/s12929-022-00841-y
- By:
- Publication type:
- Article
A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions.
- Published in:
- Journal of Biomedical Science, 2021, v. 28, n. 1, p. 1, doi. 10.1186/s12929-021-00729-3
- By:
- Publication type:
- Article
Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8<sup>+</sup> T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093162
- By:
- Publication type:
- Article
Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056912
- By:
- Publication type:
- Article
Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.755995
- By:
- Publication type:
- Article